Role for ribosome-associated quality control in sampling proteins for MHC class I-mediated antigen presentation

Mammalian cells present a fingerprint of their proteome to the adaptive immune system through the display of endogenous peptides on MHC-I complexes. MHC-I–bound peptides originate from protein degradation by the proteasome, suggesting that stably folded, long-lived proteins could evade monitoring. H...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 117; no. 8; pp. 4099 - 4108
Main Authors: Trentini, Débora Broch, Pecoraro, Matteo, Tiwary, Shivani, Cox, Jürgen, Mann, Matthias, Hipp, Mark S., Hartl, F. Ulrich
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 25-02-2020
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mammalian cells present a fingerprint of their proteome to the adaptive immune system through the display of endogenous peptides on MHC-I complexes. MHC-I–bound peptides originate from protein degradation by the proteasome, suggesting that stably folded, long-lived proteins could evade monitoring. Here, we investigate the role in antigen presentation of the ribosome-associated quality control (RQC) pathway for the degradation of nascent polypeptides that are encoded by defective messenger RNAs and undergo stalling at the ribosome during translation. We find that degradation of model proteins by RQC results in efficient MHC-I presentation, independent of their intrinsic folding properties. Quantitative profiling of MHC-I peptides in wild-type and RQC-deficient cells by mass spectrometry showed that RQC substantially contributes to the composition of the immunopeptidome. Our results also identify endogenous substrates of the RQC pathway in human cells and provide insight into common principles causing ribosome stalling under physiological conditions.
Bibliography:Edited by Alexander Varshavsky, California Institute of Technology, Pasadena, CA, and approved January 20, 2020 (received for review August 21, 2019)
1Present addresses: Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The Netherlands; and School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, 26111 Oldenburg, Germany.
Author contributions: D.B.T., M.M., M.S.H., and F.U.H. designed research; D.B.T., M.P., and S.T. performed research; D.B.T., M.P., S.T., J.C., M.M., M.S.H., and F.U.H. analyzed data; and D.B.T., M.S.H., and F.U.H. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1914401117